TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1a(Human SARS coronavirus (SARS-CoV))
Shaanxi Panlong Pharmaceutical
US Patent
Shaanxi Panlong Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair